These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 11689590)

  • 1. Acute myeloblastic leukemia as a second malignancy in a patient with hereditary retinoblastoma.
    Nishimura S; Sato T; Ueda H; Ueda K
    J Clin Oncol; 2001 Nov; 19(21):4182-3. PubMed ID: 11689590
    [No Abstract]   [Full Text] [Related]  

  • 2. Secondary acute myeloid leukemia after etoposide therapy for retinoblastoma.
    Weintraub M; Revel-Vilk S; Charit M; Aker M; Pe'er J
    J Pediatr Hematol Oncol; 2007 Sep; 29(9):646-8. PubMed ID: 17805043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Secondary acute myelogenous leukemia in patients with retinoblastoma: is chemotherapy a factor?
    Gombos DS; Hungerford J; Abramson DH; Kingston J; Chantada G; Dunkel IJ; Antoneli CB; Greenwald M; Haik BG; Leal CA; Medina-Sanson A; Schefler AC; Veerakul G; Wieland R; Bornfeld N; Wilson MW; Yu CB
    Ophthalmology; 2007 Jul; 114(7):1378-83. PubMed ID: 17613328
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Secondary acute myelogenous leukemia following treatment with oral etoposide.
    Katato K; Flaherty L; Varterasian M
    Am J Hematol; 1996 Sep; 53(1):54-5. PubMed ID: 8813107
    [No Abstract]   [Full Text] [Related]  

  • 5. New retinoblastoma tumors in children undergoing systemic chemotherapy.
    Scott IU; Murray TG; Toledano S; O'Brien JM
    Arch Ophthalmol; 1998 Dec; 116(12):1685-6. PubMed ID: 9869808
    [No Abstract]   [Full Text] [Related]  

  • 6. [Small cell lung cancer with acute monocytic leukemia after combined chemotherapy including etoposide].
    Tamada T; Kimura K; Tabata M; Ishimori S; Tsuburaya T; Hayashi M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 May; 35(5):577-82. PubMed ID: 9234639
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Secondary acute myeloid leukemia after etoposide therapy for haemophagocytic lymphohistiocytosis.
    RamaChandran S; Ariffin H
    Pediatr Blood Cancer; 2009 Sep; 53(3):488-90. PubMed ID: 19434733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical result of prolonged primary chemotherapy in retinoblastoma patients.
    Kim JH; Yu YS; Khwarg SI; Choi HS; Shin HY; Ahn HS
    Korean J Ophthalmol; 2003 Jun; 17(1):35-43. PubMed ID: 12882506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 10. Outcomes of a two-drug chemotherapy regimen for intraocular retinoblastoma.
    Zage PE; Reitman AJ; Seshadri R; Weinstein JL; Mets MB; Zeid JL; Greenwald MJ; Strauss LC; Goldman S
    Pediatr Blood Cancer; 2008 Mar; 50(3):567-72. PubMed ID: 17729249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Complications of systemic chemotherapy as treatment of retinoblastoma.
    Benz MS; Scott IU; Murray TG; Kramer D; Toledano S
    Arch Ophthalmol; 2000 Apr; 118(4):577-8. PubMed ID: 10766148
    [No Abstract]   [Full Text] [Related]  

  • 12. Multifaceted chemotherapy for trilateral retinoblastoma.
    Dimaras H; Héon E; Doyle J; Strahlendorf C; Paton KE; Halliday W; Babyn P; Gallie BL; Chan HS
    Arch Ophthalmol; 2011 Mar; 129(3):362-5. PubMed ID: 21402997
    [No Abstract]   [Full Text] [Related]  

  • 13. A novel deep intronic low penetrance RB1 variant in a retinoblastoma family.
    Soliman SE; Racher H; Lambourne M; Matevski D; MacDonald H; Gallie B
    Ophthalmic Genet; 2018 Apr; 39(2):288-290. PubMed ID: 29099630
    [No Abstract]   [Full Text] [Related]  

  • 14. A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma.
    Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
    Acta Ophthalmol; 2014 Aug; 92(5):404-11. PubMed ID: 24119165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemoreduction for nonvisualized retinoblastoma hidden behind dense cataract.
    Nallasamy S; Ramasubramanian A; Shields CL; Tipperman R; Shields JA
    Can J Ophthalmol; 2010 Oct; 45(5):539-40. PubMed ID: 20648072
    [No Abstract]   [Full Text] [Related]  

  • 16. Visual outcome in macular retinoblastoma treated with primary chemotherapy.
    Balasubramanya R; Pushker N; Bajaj MS; Rani A; Ghose S; Arya LS
    Ophthalmologica; 2003; 217(6):417-21. PubMed ID: 14573975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Conjunctival melanoma 3 years after radiation and chemotherapy for retinoblastoma.
    Mahajan A; Shields CL; Eagle RC; Mashayekhi A; Freire JE; Shields JA
    J Pediatr Ophthalmol Strabismus; 2007; 44(5):300-2. PubMed ID: 17913173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized, controlled trial in groups C and D retinoblastoma.
    Meel R; Bakhshi S; Pushker N; Vishnubhatla S
    Ophthalmology; 2015 Feb; 122(2):433-5. PubMed ID: 25439612
    [No Abstract]   [Full Text] [Related]  

  • 19. Superselective intra-arterial chemotherapy for advanced retinoblastoma complicated by metastatic disease.
    Mathew AA; Sachdev N; Staffieri SE; McKenzie JD; Elder JE
    J AAPOS; 2015 Feb; 19(1):72-4. PubMed ID: 25727592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The success of primary chemotherapy for group D heritable retinoblastoma.
    Cohen VM; Kingston J; Hungerford JL
    Br J Ophthalmol; 2009 Jul; 93(7):887-90. PubMed ID: 18703556
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.